Some experiences do not give us neat answers. They give us better questions.
My interest in psilocybin is not purely academic. I have had a personal experience with it. I am deliberately not sharing where, when or how that experience took place, because the purpose of this article is neither to encourage unlawful use nor to offer a blueprint for it. What the experience did was lead me to look more carefully at the emerging research, the meaning people make from altered states of consciousness, and the responsibility that must accompany any conversation about potential benefit.
It also reminded me of something I see repeatedly in therapy and coaching: an insight can be powerful, but insight is not the same as integration. A meaningful experience may open a door. The enduring work lies in how we understand what emerged, how we translate it into everyday choices, and whether those choices create a safer, more aligned and sustainable life.
What is psilocybin?
Psilocybin is a naturally occurring psychedelic compound found in certain species of mushrooms. In the body, it is converted to psilocin, which affects serotonin-related pathways and can temporarily alter perception, emotion, cognition and the sense of self.
The intensity and meaning of an experience can vary considerably. Personal history, mental and physical health, expectations, environment, support and the way the experience is processed afterwards may all matter. This is one reason why a personal account—positive or negative—cannot establish that something is safe, appropriate or effective for another person.
What does the research suggest?
Clinical research has created legitimate interest in psilocybin-assisted interventions. In controlled studies involving carefully screened participants, defined protocols and structured psychological support, researchers have reported promising findings in areas including:
- Major depressive disorder: Randomised clinical trials have found reductions in depressive symptoms following psilocybin administered within structured research programmes.
- Depression and anxiety associated with life-threatening cancer: Smaller controlled trials have reported reductions in psychological distress and increases in measures such as meaning and quality of life for some participants.
- Treatment-resistant depression: Research remains mixed. Some studies report encouraging secondary outcomes, while at least one recent trial did not meet its primary endpoint and identified safety signals requiring serious attention.
The word “promising” matters. It does not mean proven for every condition, suitable for every person, or ready to be translated into an informal service. Many studies remain relatively small. Blinding is difficult because participants often know that they have received a psychedelic. Research participants are screened, monitored and supported in ways that are not reproduced by unsupervised use. The preparation, therapeutic context and integration surrounding the substance may also contribute to outcomes.
The evidence therefore deserves neither dismissal nor exaggeration. It deserves careful, continuing study.
Potential benefit is not the same as universal safety
Psilocybin can produce intense fear, confusion, panic, nausea, headaches and temporary increases in heart rate or blood pressure. It may be particularly risky for people with certain psychiatric or medical vulnerabilities. Clinical trials commonly exclude people for whom there may be an elevated risk of psychosis, mania, cardiovascular complications or harmful medication interactions.
Serious adverse reactions appear uncommon in screened research settings, but uncommon does not mean impossible. Recent research has also reinforced the importance of monitoring suicidal thinking and other adverse psychological effects. A compelling personal story should never be used to bypass individual screening, informed consent, medical oversight or the limits of the evidence.
The South African legal position
Psilocybin and psilocin remain controlled substances in South Africa. Their acquisition, possession, use, manufacture and supply are prohibited outside narrowly authorised legal pathways, such as approved research. The legal position may evolve, but promising international research does not make general use or the commercial provision of psilocybin journeys lawful in South Africa.
For that reason, Healing Energy Therapy & Coaching does not offer, provide, arrange or facilitate psilocybin journeys. This article is educational and reflective. It is not an invitation to book such a service, a recommendation to use psilocybin, or legal or medical advice.
The work after the experience
One of the most useful distinctions in this field is the difference between an experience and what a person does with it afterwards. An altered state can feel profound. Yet intensity is not the same as truth, and revelation is not the same as transformation.
Integration is the slower process of examining what arose, testing it against reality and values, and deciding what belongs in ordinary life. It may include reflective writing, appropriate psychological support, rest, attention to relationships, and small behavioural changes that can be sustained.
Integration should never be used to legitimise or facilitate unlawful substance use, nor should a practitioner present ordinary counselling or coaching as covert psychedelic treatment.
My conclusion
My experience left me more curious, but also more careful. I can respect the significance that some people attach to psilocybin experiences while remaining honest about the law, the risks and the limitations of current knowledge.
We do not serve people well by reducing the conversation to either “miracle treatment” or “nothing of value here.” Responsible curiosity can hold two truths at once: the research is worthy of attention, and the safeguards matter.
The task is not to chase a powerful moment. It is to ask whether what follows helps a person live with greater truth, responsibility, connection and care.
Important notice
This article is provided for general educational and reflective purposes only. It is not medical, psychological or legal advice and does not encourage the possession or use of an unlawful substance. Healing Energy Therapy & Coaching does not offer, arrange or facilitate psilocybin services. Anyone considering participation in lawful clinical research should obtain independent medical advice and use properly authorised research channels.
Selected sources